Get started
Author

Pentti Põder

Observed names: P Põder, P. Poder, Pentti Poder
ORCID: 0000-0002-2566-1783
Observed ORCID: 0000-0002-2566-1783
OpenAlex ID: A5041375595
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
2023 · Theresa A McDonagh, Marco Metra, et al. · European Heart Journal · 2,927
PDF
2015 ESC Guidelines for the diagnosis and management of pericardial diseases
2015 · Yehuda Adler, Philippe Charron, et al. · European Heart Journal · 2,727
PDF
Levosimendan vs Dobutamine for Patients With Acute Decompensated Heart Failure
2007 · Alexandre Mebazaa, Markku S. Nieminen, et al. · JAMA · 993
Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure
2012 · M. Nikolaou, J. Parissis, et al. · European Heart Journal · 333
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use
2020 · Zoltán Papp, Piergiuseppe Agostoni, et al. · Journal of Cardiovascular Pharmacology · 114
2026 ESC Guidelines for the management of heart failure
2026 · Lars Køber, Marianna Adamo, et al. · European Heart Journal · 101
The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinion
2016 · Markku S. Nieminen, Michael Buerke, et al. · International Journal of Cardiology · 83
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use
2020 · Zoltán Papp, Piergiuseppe Agostoni, et al. · Cardiac failure review · 73
PDF
A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus
2019 · Dimitrios Farmakis, Piergiuseppe Agostoni, et al. · International Journal of Cardiology · 69
Oral Levosimendan in Patients with Severe Chronic Heart Failure—The PERSIST Study
2008 · Markku S. Nieminen, John G.F. Cleland, et al. · European Journal of Heart Failure · 60
PDF
Navigating between Scylla and Charybdis: challenges and strategies for implementing guideline‐directed medical therapy in heart failure with reduced ejection fraction
2021 · Petar M. Seferović, Marija Polovina, et al. · European Journal of Heart Failure · 59
PDF
The utility of levosimendan in the treatment of heart failure
2006 · Lasse Lehtonen, Pentti Põder · Annals of Medicine · 41
PDF
Pharmacodynamics and Pharmacokinetics of Oral Levosimendan and Its Metabolites in Patients With Severe Congestive Heart Failure: A Dosing Interval Study
2004 · Pentti Põder, Jaan Eha, et al. · The Journal of Clinical Pharmacology · 36
Serum uric acid and outcomes in patients with chronic heart failure through the whole spectrum of ejection fraction phenotypes: Analysis of the ESC-EORP Heart Failure Long-Term (HF LT) Registry
2021 · Giuseppe Ambrosio, Marisa G. Crespo Leiro, et al. · European Journal of Internal Medicine · 33
Short-Term Therapies for Treatment of Acute and Advanced Heart Failure—Why so Few Drugs Available in Clinical Use, Why Even Fewer in the Pipeline?
2019 · Piero Pollesello, Tuvia Ben Gal, et al. · Journal of Clinical Medicine · 22
PDF
Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. a randomized, placebo-controlled, double-blind study (RUSSLAN)
2003 · V.S. Moiseyev, P. Poder, et al. · ACC Current Journal Review · 19
Pharmacodynamic Interactions of Levosimendan and Felodipine in Patients with Coronary Heart Disease
2003 · Pentti Põder, Jaan Eha, et al. · Cardiovascular Drugs and Therapy · 15
Study design of a mortality trial with intravenous levosimendan - the SURVIVE study - in patients with acutely decompensated heart failure
2004 · A. Mebazaa, A. Cohen-Solal, et al. · Journal of Cardiac Failure · 12
Study design of a mortality trial with intravenous levosimendan (the SURVIVE study) in patients with acutely decompensated heart failure
2004 · A Mebazaa, A Cohen-Solal, et al. · Critical Care · 11
PDF
Randomized study on safety and effectiveness of levosimendan in patients with left ventricular failure after an acute myocardial infarct
1999 · Valentin S. Moiseyev, Nikolajs Andrejevs, et al. · Journal of Cardiac Failure · 9
Patient perception of anticoagulant treatment for stroke prevention (RE-SONANCE study)
2020 · Dragos Vinereanu, Dmitry Napalkov, et al. · Open Heart · 7
PDF
Patient perceptions of anticoagulant treatment with dabigatran or a vitamin K antagonist for stroke prevention in atrial fibrillation according to region and age: an exploratory analysis from the RE-SONANCE study
2021 · Dragos Vinereanu, Dmitry Napalkov, et al. · Journal of Thrombosis and Thrombolysis
PDF
Levosimendan in patients with ischaemic heart disease
2006 · Pentti Põder · Työväentutkimus Vuosikirja
Works count: 24
Citation count: 7,744
H-index: 16
I10-index: 19
Year
Topic
Type